ArticleOncotarget2020

Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with

Adélia Mendes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.